ATLANTA — A pet drug maker is making a big change on their labels for their new arthritis shot after Channel 2 Action News ...
The animal-health company added warnings about side effects such as seizures and paralysis to the label for Librela.
Zoetis Inc. today announced that it has updated the U.S. label for Librela® (bedinvetmab injection), following its submission ...
Librela (bedinvetmab injection) is a monthly injectable monoclonal antibody, for which real-world drug experience data has ...
PARSIPPANY, N.J. - Zoetis Inc . (NYSE: NYSE:ZTS), a global leader in animal health with a market capitalization of $77.57 billion, has announced an immediate update to the U.S. label for its canine ...
Zoetis (ZTS) announced that it has updated the U.S. label for Librela, following its submission of a supplement to the FDA. This supplement ...
Investing.com -- Zoetis Inc remains a standout in the struggling animal health sector, benefiting from its pricing power and portfolio of irreplaceable therapeutics, according to a Piper Sandler ...
Reports Q2 revenue $309.3M, consensus $316.5M. “Phibro has achieved exceptional results this quarter, fueled by robust demand in our Animal ...
Learn more about whether Sanofi or Zoetis Inc. is a better investment based on AAII's A+ Investor grades, which compare both ...